NWF Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

NWF Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468K	Hold	1,680	–	–	0.05%	220
2025 Q4	$509K	Hold	1,680	–	–	0.06%	209
2025 Q3	$471K	Sell	1,680 -100	-6%	-$27.2K	0.05%	222
2025 Q2	$430K	Hold	1,780	–	–	0.05%	232
2025 Q1	$434K	Buy	+1,780	New	+$535K	0.06%	192
2024 Q4	–	Sell	-1,780	Closed	-$596K	–	299
2024 Q3	$596K	Hold	1,780	–	–	0.09%	147
2024 Q2	$486K	Hold	1,780	–	–	0.08%	161
2024 Q1	$616K	Hold	1,780	–	–	0.1%	140
2023 Q4	$575K	Hold	1,780	–	–	0.11%	133
2023 Q3	$638K	Hold	1,780	–	–	0.15%	112
2023 Q2	$675K	Hold	1,780	–	–	0.16%	112
2023 Q1	$675K	Buy	+1,780	New	+$833K	0.16%	112

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NWF Advisory Services's BIO Position: Q1 2026 in Review

NWF Advisory Services held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2026 at 1,680 shares worth $468K. The position accounts for 0.05% of the portfolio, ranked #220.

NWF Advisory Services first reported a position in BIO in Q1 2023 and has held it in 12 quarters since. The position peaked at $675K in Q2 2023. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

NWF Advisory Services held 1,680 shares of Bio-Rad Laboratories Class A worth $468K as of Q1 2026.
NWF Advisory Services left its Bio-Rad Laboratories Class A share count unchanged in Q1 2026.
Bio-Rad Laboratories Class A made up 0.05% of NWF Advisory Services's portfolio in Q1 2026, its #220 holding.
NWF Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 12 quarters since.
NWF Advisory Services's Bio-Rad Laboratories Class A position peaked at $675K in Q2 2023.
391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.